Results 21 to 30 of about 1,820,387 (299)

Stem cell therapy in pulmonary hypertension: current practice and future opportunities

open access: yesEuropean Respiratory Review, 2023
Pulmonary hypertension (PH) is a progressive disease characterised by elevated pulmonary arterial pressure and right-sided heart failure. While conventional drug therapies, including prostacyclin analogues, endothelin receptor antagonists and ...
Ruixuan Zheng   +5 more
doaj   +1 more source

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease

open access: yesGenome Medicine, 2018
Pulmonary arterial hypertension (PAH) is a rare disease characterized by distinctive changes in pulmonary arterioles that lead to progressive pulmonary arterial pressures, right-sided heart failure, and a high mortality rate.
N. Zhu   +21 more
semanticscholar   +1 more source

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease

open access: yesPulmonary Circulation, 2018
There are few randomised controlled data to guide management of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD).
R. Condliffe   +3 more
doaj   +1 more source

Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and its Prognostic Value in Pulmonary Hypertension due to Left Heart Disease

open access: yesCirculation: Heart Failure, 2018
Background: Patients with combined post- and precapillary pulmonary hypertension due to left heart disease have a worse prognosis compared with isolated postcapillary.
Emmanouil Tampakakis   +14 more
semanticscholar   +1 more source

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

open access: yesEuropean Heart Journal, 2017
Aims We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD).
Javier Bermejo   +97 more
semanticscholar   +1 more source

A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease

open access: yesERJ Open Research, 2018
European Respiratory Society (ERS) guidelines recommend the assessment of patients with interstitial lung disease (ILD) and severe pulmonary hypertension (PH), as defined by a mean pulmonary artery pressure (mPAP) ≥35 mmHg at right heart catheterisation (
Simon Bax   +17 more
doaj   +1 more source

Application of Artificial Intelligence-Based Auxiliary Diagnosis in Congenital Heart Disease Screening

open access: yesAnatolian Journal of Cardiology, 2023
Background: To evaluate the application value of artificial intelligence-based auxiliary diagnosis for congenital heart disease. Methods: From May 2017 to December 2019, 1892 cases of congenital heart disease heart sounds were collected for learning ...
Hongbo Yang   +4 more
doaj   +1 more source

Cor pulmonale in canine patients

open access: yesCiencia Veterinaria, 2020
When we talk about cor pulmonale or pulmonary heart disease we refer to a heart that has been disrupted its structure and, therefore, its function as a result of chronic pulmonary disease.
Roberto Andrés Sosa   +2 more
doaj   +1 more source

THE HEART IN PULMONARY TUBERCULOSIS [PDF]

open access: yesSouthern Medical Journal, 1908
n ...
openaire   +1 more source

High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation

open access: yesPulmonary Circulation, 2019
Atrial septal defect (ASD) is one of the most frequent congenital heart diseases (CHD). Up to 10% of adults with an ASD develop pulmonary arterial hypertension (PAH, PAH-CHD) in their lifetime.
Christopher Hohmann   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy